Which impose greater myelosuppressive burdens; second, advanced tumors are often accompanied by systemic deterioration, including malnutrition, systemic inflammatory response (elevated CRP), and organ dysfunction, all of which impair tolerance to chemotherapy toxicity (Lalami and Klastersky, 2017; Hagiwara et al., 2022). The gene discussed is CRP; the disease is nutritional deficiency disease.